The next generation of RAGE modulators: implications for soluble RAGE therapies in vascular inflammation.
作者信息
Bowman Marion A Hofmann, Schmidt Ann Marie
机构信息
Department of Medicine, University of Chicago, Chicago, IL, USA,
出版信息
J Mol Med (Berl). 2013 Dec;91(12):1329-31. doi: 10.1007/s00109-013-1097-y.
Abstract
摘要
相似文献
1
The next generation of RAGE modulators: implications for soluble RAGE therapies in vascular inflammation.下一代晚期糖基化终末产物受体调节剂：对血管炎症中可溶性晚期糖基化终末产物受体疗法的启示。
J Mol Med (Berl). 2013 Dec;91(12):1329-31. doi: 10.1007/s00109-013-1097-y.
2
Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.晚期糖基化终末产物可溶性受体：从疾病标志物到潜在治疗靶点。
Curr Med Chem. 2006;13(17):1971-8. doi: 10.2174/092986706777585013.
3
Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.晚期糖基化终末产物受体的激活：糖尿病血管病变和动脉粥样硬化中慢性血管功能障碍的一种机制。
Circ Res. 1999 Mar 19;84(5):489-97. doi: 10.1161/01.res.84.5.489.
4
RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.晚期糖基化终末产物受体（RAGE）、RAGE配体及其在癌症与炎症中的作用。
J Transl Med. 2009 Mar 17;7:17. doi: 10.1186/1479-5876-7-17.
5
Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.晚期糖基化终末产物受体的晚期糖基化终末产物配体：生化特性及形成动力学
Anal Biochem. 2004 Jan 1;324(1):68-78. doi: 10.1016/j.ab.2003.09.013.
6
RAGE and RAGE ligands in cancer.癌症中的晚期糖基化终末产物受体及其配体
Curr Mol Med. 2007 Dec;7(8):777-89. doi: 10.2174/156652407783220697.
7
Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure.晚期糖基化终末产物受体（RAGE）及其在心力衰竭病理生理学中的意义。
Curr Heart Fail Rep. 2012 Jun;9(2):107-16. doi: 10.1007/s11897-012-0089-5.
8
The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome.晚期糖基化终产物受体与急性肺损伤/急性呼吸窘迫综合征。
Intensive Care Med. 2012 Oct;38(10):1588-98. doi: 10.1007/s00134-012-2624-y. Epub 2012 Jul 10.
9
Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.低糖降解产物腹膜透析方案与较低的血浆晚期糖基化终产物受体的促炎配体EN-RAGE和HMGB-1相关。
Ther Apher Dial. 2014 Jun;18(3):309-16. doi: 10.1111/1744-9987.12103.
10
Soluble RAGE-modulating drugs: state-of-the-art and future perspectives for targeting vascular inflammation.可溶性 RAGE 调节药物：靶向血管炎症的最新技术和未来展望。
Curr Vasc Pharmacol. 2010 Jan;8(1):86-92. doi: 10.2174/157016110790226642.
引用本文的文献
1
Plasma Concentration of Advanced Glycation End-Products From Wild Canids and Domestic Dogs Does Not Change With Age or Across Body Masses.野生犬科动物和家犬体内晚期糖基化终产物的血浆浓度不会随年龄或体重的变化而改变。
Front Vet Sci. 2021 Jan 26;8:637132. doi: 10.3389/fvets.2021.637132. eCollection 2021.
2
Lysophosphatidic Acid Signaling in Diabetic Nephropathy.溶血磷脂酸信号在糖尿病肾病中的作用。
Int J Mol Sci. 2019 Jun 11;20(11):2850. doi: 10.3390/ijms20112850.
3
The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality.晚期糖基化终产物在衰老和代谢性疾病中的作用：关联与因果关系的桥梁。
Cell Metab. 2018 Sep 4;28(3):337-352. doi: 10.1016/j.cmet.2018.08.014.
4
Soluble Receptor for Advanced Glycation End Product Ameliorates Chronic Intermittent Hypoxia Induced Renal Injury, Inflammation, and Apoptosis via P38/JNK Signaling Pathways.晚期糖基化终末产物可溶性受体通过P38/JNK信号通路改善慢性间歇性缺氧诱导的肾损伤、炎症和细胞凋亡。
Oxid Med Cell Longev. 2016;2016:1015390. doi: 10.1155/2016/1015390. Epub 2016 Sep 5.
5
S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.S100A12与S100/钙粒蛋白：动脉粥样硬化新出现的生物标志物及可能的治疗靶点
Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2496-507. doi: 10.1161/ATVBAHA.115.302072. Epub 2015 Oct 29.
6
Vessel ultrasound sonographic assessment of soluble receptor for advanced glycation end products efficacy in a rat balloon injury model.血管超声对晚期糖基化终末产物可溶性受体在大鼠球囊损伤模型中疗效的评估
Curr Ther Res Clin Exp. 2014 Nov 11;76:110-5. doi: 10.1016/j.curtheres.2014.08.001. eCollection 2014 Dec.
7
Ischemia-reperfusion injury of the retina is linked to necroptosis via the ERK1/2-RIP3 pathway.视网膜缺血再灌注损伤通过ERK1/2-RIP3途径与坏死性凋亡相关联。
Mol Vis. 2014 Sep 24;20:1374-87. eCollection 2014.
8
Medial vascular calcification revisited: review and perspectives.再探血管内侧钙化：综述与展望
Eur Heart J. 2014 Jun 14;35(23):1515-25. doi: 10.1093/eurheartj/ehu163. Epub 2014 Apr 16.
本文引用的文献
1
The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth.sRAGE 的 N-糖型是其减轻损伤诱导的动脉炎症和内膜增生的治疗效果的关键决定因素。
J Mol Med (Berl). 2013 Dec;91(12):1369-81. doi: 10.1007/s00109-013-1091-4. Epub 2013 Oct 17.
2
Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.心血管炎症减少试验的原理和设计：对动脉粥样硬化血栓形成炎症假说的检验。
Am Heart J. 2013 Aug;166(2):199-207.e15. doi: 10.1016/j.ahj.2013.03.018. Epub 2013 May 3.
3
Alarmins: awaiting a clinical response.警报素：等待临床响应。
J Clin Invest. 2012 Aug;122(8):2711-9. doi: 10.1172/JCI62423. Epub 2012 Aug 1.
4
S100A12 expression in thoracic aortic aneurysm is associated with increased risk of dissection and perioperative complications.S100A12 在胸主动脉瘤中的表达与夹层形成风险增加和围手术期并发症相关。
J Am Coll Cardiol. 2012 Aug 21;60(8):775-85. doi: 10.1016/j.jacc.2012.04.027. Epub 2012 Jul 18.
5
S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program.S100A12 在载脂蛋白 E 基因敲除小鼠的血管平滑肌中通过激活成骨基因调控程序加速血管钙化。
Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):337-44. doi: 10.1161/ATVBAHA.110.217745. Epub 2010 Oct 21.
6
Carboxylated N-glycans on RAGE promote S100A12 binding and signaling.糖基化终产物受体（RAGE）上的羧基化 N-聚糖促进 S100A12 的结合和信号转导。
J Cell Biochem. 2010 Jun 1;110(3):645-59. doi: 10.1002/jcb.22575.
7
The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.RAGE 轴：对脆弱血管发出危险信号的基本机制。
Circ Res. 2010 Mar 19;106(5):842-53. doi: 10.1161/CIRCRESAHA.109.212217.
8
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.在载脂蛋白E基因敲除（apoE-/-）小鼠中，血管和炎症应激通过晚期糖基化终末产物受体（RAGE）及其配体介导动脉粥样硬化。
J Clin Invest. 2008 Jan;118(1):183-94. doi: 10.1172/JCI32703.
9
Central role of RAGE-dependent neointimal expansion in arterial restenosis.RAGE 依赖性新生内膜扩张在动脉再狭窄中的核心作用。
J Clin Invest. 2003 Apr;111(7):959-72. doi: 10.1172/JCI17115.
10
Atherosclerosis--an inflammatory disease.动脉粥样硬化——一种炎症性疾病。
N Engl J Med. 1999 Jan 14;340(2):115-26. doi: 10.1056/NEJM199901143400207.
Zotero 插件